Showing 611-620 of 7665 results for "".
- Study: Bile Acids May Improve Skin Inflammation in Psoriasishttps://practicaldermatology.com/news/study-bile-acids-may-improve-skin-inflammation-in-psoriasis/2461067/Taking bile acids may help control inflammation caused by psoriasis, a UC Davis Health study has found. The study, published in the Journal of Investigative Dermatology, suggests that bile acids may treat psoriasis by stopping immune T cells from producing IL-17A and blocking the immune cell movem…
- Study: Knowledge of Skin Cancer Risk May Limit Tanning Bed Use, Unhealthy Behaviorshttps://practicaldermatology.com/news/study-knowledge-of-skin-cancer-risk-may-limit-tanning-bed-use-unhealthy-behaviors/2461064/When patients know their risk for skin cancer, they may change their behaviors to lower their chances of developing melanoma, a new study suggests. A recent Mayo Clinic study published in Dermatologic Surgery examined the role of risk perception in limiting potential behavior that could increase …
- Dupixent Update: Medication Shows Promise in Five Inflammatory Diseaseshttps://practicaldermatology.com/news/dupixent-update-medication-shows-promise-in-five-inflammatory-diseases/2461063/Dupixent (dupilumab) performed well across five diseases with underlying type 2 inflammation. The five diseases include eosinophilic esophagitis, chronic spontaneous urticaria, asthma, chronic rhinosinusitis with nasal polyposis, and atopic dermatitis. Additionally, positive results from two Phase…
- Merz Aesthetics Launches Radiesse (+) as First and Only Aesthetic Injectable to Improve Moderate to Severe Loss of Jawline Contourhttps://practicaldermatology.com/news/merz-aesthetics-launches-radiesse-as-first-and-only-aesthetic-injectable-to-improve-moderate-to-severe-loss-of-jawline-contour/2461062/Merz Aesthetics is launching Radiesse (+) Lidocaine for jawline contouring in adults over the age of 21. Radiesse (+) is the first and only U.S. Food and Drug Administration (FDA)-approved injectable treatment for jawline contour improvement. The FDA approved the supplemental Premarket Approval Ap…
- Study: Retinol Plus CBD Maintains Anti-Aging Properties Minus Side Effectshttps://practicaldermatology.com/news/study-retinol-plus-cbd-maintains-anti-aging-properties-minus-side-effects/2461059/Combining a retinol and cannabidiol (CBD) in topical skincare maintains retinol’s anti-aging properties with reduced side effects, a new study in Aesthetic Surgery Journal shows. “CBD is anti-inflammatory and pro-healing in nature. I believe that the anti-inflammatory and antioxidant properties pr…
- Morgan Dermatology to Expand with Financing from TD Bankhttps://practicaldermatology.com/news/morgan-dermatology-to-expand-with-financing-from-td-bank/2461058/Morgan Dermatology is expanding, thanks to a $1.38 million term loan and $5.26 million Commercial Real Estate Mortgage (CREM) from TD Bank and its Healthcare Practice Solutions Group (HPSG). The financing will enable Morgan Dermatology to relocate from its current 5,000-square-foot facility to a mo…
- Nevisense Boosts Clinician Confidence in Early Melanoma Diagnosishttps://practicaldermatology.com/news/nevisense-boosts-clinicians-confidence-in-early-melanoma-diagnosis/2461053/Nevisense provides valuable diagnostic guidance for clinicans when evaluating atypical pigmented skin lesions, according to a new study. The Nevisense method uses small electrical impulses to detect cellular irregularities beneath the skin’s surface. In the pilot study, mean confidence for clinic…
- Survey Reveals Impact of AGA on Affected Men, Interest in New Therapieshttps://practicaldermatology.com/news/survey-reveals-impact-of-aga-on-affected-men-interest-in-new-therapies/2461046/Nearly two-thirds (64%) of men with androgentic alopecia (AGA) say the condition has a negative affect on their lives, yet more than half (56%) have never sought treatment for the condition, results of a survey show. Findings from the survey, conducted on behalf of Follica, Inc., were accepted as …
- Scientis: Mikki Bey Crawford Named US VP and General Manager, Aesthetic Dermatologyhttps://practicaldermatology.com/news/scientis-mikki-bey-crawford-named-us-vp-and-general-manager-aesthetic-dermatology/2461045/Mikki Bey Crawford is now US Vice President and General Manager, Aesthetic Dermatology for Scientis. In her new role, she will lead the sales and marketing teams to accelerate the growth of Cyspera® in the US. "We are so pleased to add Mikki to the Cyspera® leadership team," says Jean-Francois Gou…
- FDA Approves Pfizer's Cibinqo for Moderate-to-Severe AD in Adultshttps://practicaldermatology.com/news/fda-approves-pfizers-cibinqo-for-moderate-to-severe-ad-in-adults/2461037/Pfizer's Cibinqo® (abrocitinib), an oral, once-daily, Janus kinase 1 (JAK1) inhibitor, is now FDA approved for the treatment of adults with refractory, moderate-to-severe atopic dermatitis (AD) whose disease is not adequately controlled with other systemic drug products, including biologics, or whe…